News

SOCMA’s new members include: Arichem, Huffmaster, Marsh USA, NCM Hersbit Chemical and NCM Hersbit Chemical. The companies, who range from specialty chemical manufacturers to security providers to insurance

The approval of Dulera is based, in part, on Phase III studies that evaluated the safety and efficacy in patients 12 years of age and older with persistent

miRagen is planning to develop and commercialise single-stranded LNA-based product candidates intended for the treatment of cardiovascular disease by utilizing Santaris Pharma proprietary Locked Nucleic Acid (LNA) Drug

The worldwide suspension of the program, which is effective immediately, follows a small number of reports of Pfizer Tanezumab patients experiencing the worsening of osteoarthritis leading to joint

According to BioSurplus, for the past 15 years, Ms Scott served as a partner with RA Capital Advisors, a private investment bank, where she completed financial transactions totaling

According to Frost & Sullivan analysis most pharmaceutical companies consider emerging markets lucrative due to their economical infrastructure and manpower costs and a significant untapped market potential with

The patent, when issued, will provide Japanese patent protection to September 2021 and is one in a series of patents and pending applications that NexMed owns on Vitaros

Cellceutix said that its team has identified an animal model and has been successful in chemically inducing these characteristics in the model. KM-391 has shown to be successful

Neogenix said that the USPT0 has issued a patent for the NPC-1C monoclonal antibody and a related divisional patent was granted with respect to the genes encoding the